The Senior Financial Analyst supports global accounting operations by delivering accurate financial analysis, reconciliations, and close and planning cycle support. This role helps maintain reliable financial data, with emphasis on intragroup profit elimination and transactional FX reporting.
RESPONSIBILITIES
Support execution of month-end close and planning activities related to Intragroup Profit (IGP) and Transactional FX.
Prepare and post journal entries
Analyze Intragroup Profit (IGP) and Transactional FX results and explain variances between actual and plan.
Support Internal/External audit requests as required
Support the continuous improvement of business practices/procedures by leveraging systems and best practices.
Supports other key initiatives and performs ad-hoc analysis as defined by Senior Management.
Education Requirements
ACA, ACCA or equivalent accounting qualification
Bachelor’s degree (or equivalent) in accounting, mathematics or finance or related discipline
Experience Requirements
3–5 years of experience in financial reporting and analysis, including work in multi-site global environments.
Strong financial modeling experience.
Advanced proficiency with Microsoft Office applications, particularly Excel.
SAP knowledge is strongly preferred.
Skilled in quantitative analysis and modeling.
Experience working with multiple currencies.
Able to thrive in a fast-paced, high-volume environment while communicating effectively with all levels of the organization.
Effectively manages overlapping projects, adapts to change, learns quickly, solves complex problems, perseveres through challenges, and remains focused on customer needs.
Works effectively across cultures to achieve objectives.
The role is based in Speke, Liverpool
Hybrid role: Office based 3-days a week
#LI-Hybrid
CSL Seqirus is part of CSL. As one of the largest influenza vaccine providers in the world, CSL Seqirus is a major contributor to the prevention of influenza globally and a transcontinental partner in pandemic preparedness. With state-of-the-art production facilities in the U.S., the U.K. and Australia, CSL Seqirus utilizes egg, cell and adjuvant technologies to offer a broad portfolio of differentiated influenza vaccines in more than 20 countries around the world.
To learn more about CSL, CSL Behring, CSL Seqirus and CSL Vifor visit https://www.csl.com/ and CSL Plasma at https://www.cslplasma.com/.
Our Benefits
For more information on CSL benefits visit How CSL Supports Your Well-being | CSL.
You Belong at CSL
At CSL, Inclusion and Belonging is at the core of our mission and who we are. It fuels our innovation day in and day out. By celebrating our differences and creating a culture of curiosity and empathy, we are able to better understand and connect with our patients and donors, foster strong relationships with our stakeholders, and sustain a diverse workforce that will move our company and industry into the future.
To learn more about inclusion and belonging visit https://www.csl.com/careers/inclusion-and-belonging
Equal Opportunity Employer
CSL is an Equal Opportunity Employer. If you are an individual with a disability and need a reasonable accommodation for any part of the application process, please visit https://www.csl.com/accessibility-statement.
Watch our ‘On the Front Line’ video to learn more about CSL Seqirus
Skills Required
- ACA, ACCA, or equivalent accounting qualification
- Bachelor’s degree or equivalent in accounting, mathematics, finance, or a related discipline
- 3–5 years of experience in financial reporting and analysis, including multi-site global environments
- Strong financial modeling experience
- Advanced proficiency with Microsoft Office applications, particularly Excel
- SAP knowledge
- Quantitative analysis and modeling skills
- Experience working with multiple currencies
- Effective communication across organizational levels and cultures
What We Do
CSL is a leading global biotechnology company with a dynamic portfolio of lifesaving medicines, including those that treat haemophilia and immune deficiencies, vaccines to prevent influenza, and therapies in iron deficiency, dialysis and nephrology. Since our start in 1916, we have been driven by our promise to save lives using the latest technologies. Today, CSL – including our businesses, CSL Behring, CSL Seqirus, CSL Plasma and CSL Vifor – provides lifesaving products to patients in more than 100 countries and employs 32,000 people. Our unique combination of commercial strength, R&D focus and operational excellence enables us to identify, develop and deliver innovations so our patients can live life to the fullest. See our community guidelines: https://bit.ly/3Bs17Ra
